Annals of Oncology

SJR Rank #14H-index: 331SJR: 21.715Best quartile: Q1APC: US$5,080
Journal website: aims, scope and author guidelines
Publisher

Elsevier Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202506121824

Subject Categories

  • HematologyQ1
  • Medicine (miscellaneous)Q1
  • OncologyQ1

Areas: Medicine

Most published research topics

Lung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesCancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsCancer Treatment and PharmacologyGastric Cancer Management and OutcomesLung Cancer Research StudiesHER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesPancreatic and Hepatic Oncology Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025065130195260

Detailed Information

ISSN

1569-8041, 0923-7534

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

25.93

References per Document

28.21

Coverage

1990-2026

Scope

Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine. Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.

Metrics from SCImago Journal Rank 2025. View on SCImago